PEMETREXED DISODIUM FOR INJECTION DIN 02554542
Status: Approved
Holder: HIKMA CANADA LIMITED
Health Canada record
| Active ingredient(s) | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 500 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01BA04 PEMETREXED |
| Original market date | |
| Current status date | 28-Jan-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hikma Canada Limited — licence 3-002579, currently licensed, last inspection rating C (2022-04-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02438674 | PEMETREXED DISODIUM FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 100 MG | Marketed |
| 02438682 | PEMETREXED DISODIUM FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 500 MG | Marketed |
| 02472619 | PEMETREXED DISODIUM FOR INJECTION | MARCAN PHARMACEUTICALS INC | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 500 MG | Approved |
| 02554534 | PEMETREXED DISODIUM FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 100 MG | Approved |
| 02482967 | PEMETREXED DISODIUM FOR INJECTION USP | MARCAN PHARMACEUTICALS INC | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 100 MG | Approved |
| 02515423 | PEMETREXED FOR INJECTION | ACCORD HEALTHCARE INC | Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 25 MG | Marketed |
| 02454629 | PEMETREXED DISODIUM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 500 MG | Cancelled Pre Market |
| 02454637 | PEMETREXED DISODIUM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 1000 MG | Cancelled Pre Market |
| 02441616 | PEMETREXED DISODIUM FOR INJECTION | MYLAN PHARMACEUTICALS ULC | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 500 MG | Cancelled Pre Market |
| 02454610 | PEMETREXED DISODIUM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) 100 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34795 | 2025-01-28 | Abbreviated New Drug Submission (ANDS) |